NMTR: an explosive biotech microcap

NMTR had an incredible run over the past month. But it appears that it has been rejected at resistance, and will retrace fib levels back toward $1.00 before exiting this wedge.

A defined risk strategy here is to buy the $1.00 puts, continue rolling them out, and then within the next month add the $1 calls to form a long straddle. Be careful as liquidity is low.
biotechstocksChart PatternsTrend Analysis

Exención de responsabilidad